Search
for
Sort by
Research 811–840 of 1000+
- Is dehydroepiandrosterone a hormone?
- Molecular basis of androgen insensitivity
- Investigation, treatment and monitoring of late‐onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations
- Finasteride
- Structure of human type II 5 alpha-reductase gene.
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Effects of in Utero Exposure to Finasteride on Androgen-Dependent Reproductive Development in the Male Rat
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- The Effects of Transdermal Dihydrotestosterone in the Aging Male: A Prospective, Randomized, Double Blind Study
- Urinary Retention in Patients with BPH Treated with Finasteride or Placebo over 4 Years
- CHRONIC TREATMENT WITH FINASTERIDE DAILY DOES NOT AFFECT SPERMATOGENESIS OR SEMEN PRODUCTION IN YOUNG MEN
- 9 Role of 5α-reductase in health and disease
- Pharmacology of antiandrogens
- Testosterone Supplementation for Aging-Associated Sarcopenia
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Critical Developmental Periods for Effects on Male Rat Genitalia Induced by Finasteride, a 5α-Reductase Inhibitor
- Potential adverse effects of long-term testosterone therapy
- Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
- Pre-receptor regulation of the androgen receptor
- Significance of the polyglutamine tract polymorphism in the androgen receptor
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- BIOLOGICAL ACTIVITY OF ANTIANDROGENS
- Selective non-steroidal inhibitors of 5α-reductase type 1
- Tamoxifen for flutamide/finasteride-induced gynecomastia
- 5α-Reduced glucocorticoids: a story of natural selection
- Acute urinary retention: risks and management.
- Cardiovascular Toxicities of Androgen Deprivation Therapy